Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Cellular Senescence With Fisetin for Improving Vascular Endothelial Function in Older Adults

NCT07871162 is registered in ClinicalTrials.gov with University of Colorado, Boulder as lead sponsor.

NCT NCT07871162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07871162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Cellular Senescence With Fisetin for Improving Vascular Endothelial Function in Older Adults
Lead sponsor
University of Colorado, Boulder
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
June 30, 2031
Enrollment
136 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging, cellular senescence, endothelial dysfunction